140 related articles for article (PubMed ID: 35580952)
1. Coats-plus syndrome: when imaging leads to genetic diagnosis.
Maia C; Batista M; Palavra F; Pinto J
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35580952
[No Abstract] [Full Text] [Related]
2. Coats Plus Syndrome.
Collin A; Lecler A
JAMA Neurol; 2019 Apr; 76(4):501. PubMed ID: 30688973
[No Abstract] [Full Text] [Related]
3. Novel biallelic missense mutations in CTC1 gene identified in a Chinese family with Coats plus syndrome.
Lin H; Gong L; Zhan S; Wang Y; Liu A
J Neurol Sci; 2017 Nov; 382():142-145. PubMed ID: 29111009
[TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing in an Indian family links Coats plus syndrome and dextrocardia with a homozygous novel CTC1 and a rare HES7 variation.
Netravathi M; Kumari R; Kapoor S; Dakle P; Dwivedi MK; Roy SD; Pandey P; Saini J; Ramakrishna A; Navalli D; Satishchandra P; Pal PK; Kumar A; Faruq M
BMC Med Genet; 2015 Feb; 16():5. PubMed ID: 25928698
[TBL] [Abstract][Full Text] [Related]
5. Novel compound heterozygous STN1 variants are associated with Coats Plus syndrome.
Acharya T; Firth HV; Dugar S; Grammatikopoulos T; Seabra L; Walters A; Crow YJ; Parker APJ
Mol Genet Genomic Med; 2021 Dec; 9(12):e1708. PubMed ID: 34110109
[TBL] [Abstract][Full Text] [Related]
6. Cerebro-retinal microangiopathy with calcifications and cysts due to recessive mutations in the CTC1 gene.
Bisserbe A; Tertian G; Buffet C; Turhan A; Lambotte O; Nasser G; Alvin P; Tardieu M; Riant F; Bergametti F; Tournier-Lasserve E; Denier C
Rev Neurol (Paris); 2015 May; 171(5):445-9. PubMed ID: 25843205
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Systemic Bevacizumab on Coats Plus Syndrome.
Boulanger E; Barjol A; Chapron T
Ophthalmol Retina; 2022 Oct; 6(10):905. PubMed ID: 35973898
[No Abstract] [Full Text] [Related]
8. Ophthalmic findings and a novel CTC1 gene mutation in coats plus syndrome: a case report.
Liang T; Zhang X; Xu Y; Zhao P
Ophthalmic Genet; 2021 Feb; 42(1):79-83. PubMed ID: 33034244
[TBL] [Abstract][Full Text] [Related]
9. [Infant with intracranial calcifications and retinopathy].
Hidalgo-Sanz J; Perez-Delgado R; Garcia-Jimenez I; Lopez-Pison J; Castillo-Castejon O; Poch ML; Izquierdo-Alvarez S
Rev Neurol; 2019 Oct; 69(7):289-292. PubMed ID: 31559627
[TBL] [Abstract][Full Text] [Related]
10. Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) or "Coats Plus": when peripheral retinal vasculature signals neurologic disease.
Mansukhani S; Ho ML; Gavrilova RH; Mohney BG; Quiram PA; Brodsky MC
J AAPOS; 2017 Oct; 21(5):420-422. PubMed ID: 28864049
[TBL] [Abstract][Full Text] [Related]
11. Coats plus syndrome (cerebroretinal microangiopathy with calcifications and cysts-1): A case report.
Morgado F; Batista M; Moreno A; Coutinho I
Pediatr Dermatol; 2021 Jan; 38(1):191-193. PubMed ID: 33010065
[TBL] [Abstract][Full Text] [Related]
12. An Indian child with Coats plus syndrome due to mutations in STN1.
Passi GR; Shamim U; Rathore S; Joshi A; Mathur A; Parveen S; Sharma P; Crow YJ; Faruq M
Am J Med Genet A; 2020 Sep; 182(9):2139-2144. PubMed ID: 32627942
[TBL] [Abstract][Full Text] [Related]
13. Cerebroretinal microangiopathy with calcifications and cysts associated with CTC1 and NDP mutations.
Romaniello R; Arrigoni F; Citterio A; Tonelli A; Sforzini C; Rizzari C; Pessina M; Triulzi F; Bassi MT; Borgatti R
J Child Neurol; 2013 Dec; 28(12):1702-8. PubMed ID: 23220793
[TBL] [Abstract][Full Text] [Related]
14. A unique case of coats plus syndrome and dyskeratosis congenita in a patient with CTC1 mutations.
Han E; Patel NA; Yannuzzi NA; Laura DM; Fan KC; Negron CI; Prakhunhungsit S; Thorson WL; Berrocal AM
Ophthalmic Genet; 2020 Aug; 41(4):363-367. PubMed ID: 32543263
[TBL] [Abstract][Full Text] [Related]
15. Leukoencephalopathy, cerebral calcifications and cysts: a family study.
Karlinger K; Tárnoki ÁD; Tárnoki DL; Polvi A; Lehesjoki AE; Kelemen A; Szegedi L; Turányi E; Kamondi A; Szűcs A
J Neurol; 2014 Oct; 261(10):1911-6. PubMed ID: 25034270
[TBL] [Abstract][Full Text] [Related]
16. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of human CTC1 mutations reveals novel mechanisms responsible for the pathogenesis of the telomere disease Coats plus.
Gu P; Chang S
Aging Cell; 2013 Dec; 12(6):1100-9. PubMed ID: 23869908
[TBL] [Abstract][Full Text] [Related]
18. [Coats Plus: Coats disease with systemic features].
Troumani Y; Ackermann F; Cohen S; Touhami S; Nasser G; Denier C; Labetoulle M; Rousseau A
J Fr Ophtalmol; 2016 Sep; 39(7):e167-70. PubMed ID: 27546161
[No Abstract] [Full Text] [Related]
19. Retinopathy and bone marrow failure revealing Coats plus syndrome.
Painho T; Conceição C; Kjöllerström P; Batalha S
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523622
[No Abstract] [Full Text] [Related]
20. Unilateral Coats'-like disease and an intragenic deletion in the TERC gene: A case report.
Peene G; Smets E; Legius E; Cassiman C
Ophthalmic Genet; 2018 Apr; 39(2):247-250. PubMed ID: 29161159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]